Azione 301093 JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Azioni

301093

CNE100004YH2

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 28/06/2024 		Variaz. 5gg Var. 1 gen.
19,26 CNY -3,80% Grafico intraday di Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. -7,18% -40,37%
14/05 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approva il dividendo in contanti per l'anno 2023 CI
25/04 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. riporta i risultati degli utili per il primo trimestre terminato il 31 marzo 2024 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves the Cash Dividend for the Year 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 301093
  4. Notizie Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
  5. Altre lingue